David Krempa | executive |
Sean Brynjelsen | executive |
James Gruber | executive |
Raghuram Selvaraju | analyst |
Good afternoon, and welcome to the Eton Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request. At this time, I'd like to turn it over to David Krempa, Chief Business Officer at Eaton Pharmaceuticals. Please proceed.
Thank you, operator.